NeoGenomics: Shashikant Kulkarni
Shashikant Kulkarni will join NeoGenomics as executive VP for research and development and CSO on March 7. Most recently, he served as CSO and senior VP of innovation and emerging business at Baylor Genetics, and as a tenured professor and vice chairman for research in the Department of Molecular and Human Genetics at Baylor College of Medicine. Previously, he was head of clinical genomics and a professor of pathology and immunology at Washington University School of Medicine in St. Louis. Kulkarni has also served as an expert panelist with several regulatory agencies, including the US Food and Drug Administration, the US Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, and the National Institutes of Health. In addition, he is the editor in chief of Cancer Genetics.